These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 31201937)

  • 21. Allopurinol is the most common cause of Stevens-Johnson syndrome and toxic epidermal necrolysis in Europe and Israel.
    Halevy S; Ghislain PD; Mockenhaupt M; Fagot JP; Bouwes Bavinck JN; Sidoroff A; Naldi L; Dunant A; Viboud C; Roujeau JC;
    J Am Acad Dermatol; 2008 Jan; 58(1):25-32. PubMed ID: 17919772
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug eruptions induced by allopurinol associated with HLA-B*5801.
    Zeng M; Zhang M; Liu F; Yan W; Kong Q; Sang H
    Indian J Dermatol Venereol Leprol; 2015; 81(1):43-5. PubMed ID: 25566896
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of the HLA-B
    Park HW; Kim DK; Kim SH; Kim S; Chae DW; Yang MS; Oh YK; Lee JP; Jung JW; Shin J; Hwang JH; Kang MG; Kim SM; Kwon SK; Kim HY; Kim MH; Kim SJ; Ryu DR; Cho YJ; Jee YK; Kim SM; Lee EK; Kim JY; Cho HS; Jeong YY; Kim SH; Jun JB; Park JS; Kim GH; Kim S; Jung HY; Lee JM
    J Allergy Clin Immunol Pract; 2019 Apr; 7(4):1271-1276. PubMed ID: 30580048
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical Pharmacogenetics Implementation Consortium guidelines for human leukocyte antigen-B genotype and allopurinol dosing.
    Hershfield MS; Callaghan JT; Tassaneeyakul W; Mushiroda T; Thorn CF; Klein TE; Lee MT
    Clin Pharmacol Ther; 2013 Feb; 93(2):153-8. PubMed ID: 23232549
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug-induced liver injury associated with severe cutaneous adverse drug reactions: A nationwide study in Taiwan.
    Huang YS; Wu CY; Chang TT; Peng CY; Lo GH; Hsu CW; Hu CT; Huang YH
    Liver Int; 2021 Nov; 41(11):2671-2680. PubMed ID: 34153177
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Presence of HLA-B75, DR13 Homozygosity, or DR14 Additionally Increases the Risk of Allopurinol-Induced Severe Cutaneous Adverse Reactions in HLA-B*58:01 Carriers.
    Shim JS; Yun J; Kim MY; Chung SJ; Oh JH; Kang DY; Jung JW; Cho SH; Kang HR
    J Allergy Clin Immunol Pract; 2019 Apr; 7(4):1261-1270. PubMed ID: 30529060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic utility of HLA-B*5801 screening in severe allopurinol hypersensitivity syndrome: an updated systematic review and meta-analysis.
    Yu KH; Yu CY; Fang YF
    Int J Rheum Dis; 2017 Sep; 20(9):1057-1071. PubMed ID: 28857441
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Research on Susceptible Genes and Immunological Pathogenesis of Cutaneous Adverse Drug Reactions in Chinese Hans.
    Yang F; Yang Y; Zhu Q; Chen SA; Fu X; Yan S; Meng C; Ma L; Sun X; Xu J; Luo X; Xing Q
    J Investig Dermatol Symp Proc; 2015 Jul; 17(1):29-31. PubMed ID: 26067314
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical features and prognostic factors in severe cutaneous drug reactions.
    Yang MS; Kang MG; Jung JW; Song WJ; Kang HR; Cho SH; Min KU
    Int Arch Allergy Immunol; 2013; 162(4):346-54. PubMed ID: 24193402
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Allopurinol-Induced Stevens-Johnson Syndrome.
    Gupta SS; Sabharwal N; Patti R; Kupfer Y
    Am J Med Sci; 2019 Apr; 357(4):348-351. PubMed ID: 30638600
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of HLA-B Allelic Variation and IFN-γ ELISpot Responses in Patients with Severe Cutaneous Adverse Reactions Associated with Drugs.
    Klaewsongkram J; Sukasem C; Thantiworasit P; Suthumchai N; Rerknimitr P; Tuchinda P; Chularojanamontri L; Srinoulprasert Y; Rerkpattanapipat T; Chanprapaph K; Disphanurat W; Chakkavittumrong P; Tovanabutra N; Srisuttiyakorn C;
    J Allergy Clin Immunol Pract; 2019 Jan; 7(1):219-227.e4. PubMed ID: 29800753
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Positive and negative associations of HLA class I alleles with allopurinol-induced SCARs in Koreans.
    Kang HR; Jee YK; Kim YS; Lee CH; Jung JW; Kim SH; Park HW; Chang YS; Jang IJ; Cho SH; Min KU; Kim SH; Lee KW;
    Pharmacogenet Genomics; 2011 May; 21(5):303-7. PubMed ID: 21301380
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Racial disparities in the risk of Stevens-Johnson Syndrome and toxic epidermal necrolysis as urate-lowering drug adverse events in the United States.
    Lu N; Rai SK; Terkeltaub R; Kim SC; Menendez ME; Choi HK
    Semin Arthritis Rheum; 2016 Oct; 46(2):253-258. PubMed ID: 27217070
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oxypurinol-Specific T Cells Possess Preferential TCR Clonotypes and Express Granulysin in Allopurinol-Induced Severe Cutaneous Adverse Reactions.
    Chung WH; Pan RY; Chu MT; Chin SW; Huang YL; Wang WC; Chang JY; Hung SI
    J Invest Dermatol; 2015 Sep; 135(9):2237-2248. PubMed ID: 25946710
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [HLA-B58.01 and allopurinol hypersensitivity renal vasculitis in a Chinese patient].
    Mariette F; Scarfoglière V; Giot M; Basire A; Rouby F; Daniel L; Jourde-Chiche N
    Rev Med Interne; 2022 Jul; 43(7):436-439. PubMed ID: 35606203
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro test to confirm diagnosis of allopurinol-induced severe cutaneous adverse reactions.
    Klaewsongkram J; Thantiworasit P; Suthumchai N; Rerknimitr P; Sukasem C; Tuchinda P; Chularojanamontri L; Srinoulprasert Y; Rerkpattanapipat T; Chanprapaph K; Disphanurat W; Chakkavittumrong P; Tovanabutra N; Srisuttiyakorn C
    Br J Dermatol; 2016 Nov; 175(5):994-1002. PubMed ID: 27106261
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Severe cutaneous adverse reactions in a local hospital setting: a 5-year retrospective study.
    Su P; Aw CW
    Int J Dermatol; 2014 Nov; 53(11):1339-45. PubMed ID: 25070588
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Direct costs of severe cutaneous adverse reactions in a tertiary hospital in Korea.
    Yang MS; Kim JY; Kang MG; Lee SY; Jung JW; Cho SH; Min KU; Kang HR
    Korean J Intern Med; 2019 Jan; 34(1):195-201. PubMed ID: 29466850
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phenotypes of Severe Cutaneous Adverse Reactions Caused by Nonsteroidal Anti-inflammatory Drugs.
    Lee SY; Nam YH; Koh YI; Kim SH; Kim S; Kang HR; Kim MH; Lee JG; Park JW; Park HK; La HO; Kim MY; Park SJ; Kwon YE; Jung JW; Kim SH; Kim CW; Yang MS; Kang MG; Lee JY; Kim JH; Kim SH; Hur GY; Jee YK; Jin HJ; Park CS; Jeong YY; Ye YM
    Allergy Asthma Immunol Res; 2019 Mar; 11(2):212-221. PubMed ID: 30661313
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HLA-B*5801: utility and cost-effectiveness in the Asia-Pacific Region.
    Yeo SI
    Int J Rheum Dis; 2013 Jun; 16(3):254-7. PubMed ID: 23981744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.